Skip to content

Based on brain-computer interface, the rehabilitation effect of acupuncture Hegu and Taichong combined with in vitro anti-Bo therapy in patients with cognitive dysfunction was explored

Based on brain-computer interface, the rehabilitation effect of acupuncture Hegu and Taichong combined with in vitro anti-Bo therapy in patients with cognitive dysfunction was explored

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082447
Enrollment
Unknown
Registered
2024-03-29
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment

Interventions

Experimental group :Experimental:On the basis of traditional medicine and rehabilitation treatment, brain-computer interface + extracorporeal counterpulsation + traditional Chinese medicine acupunctur
Control group one:The patients were treated with traditional medicine and rehabilitation treatment.
Control group two:The patients were treated with traditional medicine and rehabilitation treatment group + acupuncture Hegu and Taichong + brain-computer interface
Control group three:The patients were treated with traditional medicine and rehabilitation treatment group + acupuncture Hegu and Taichong + external counterpulsation
Control group four:The patients were treated with traditional medicine and rehabilitation treatment group + brain-computer interface + extracorporeal counterpulsation

Sponsors

Nanyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The diagnosis of cerebral infarction met the diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018. (1) Cognitive dysfunction: Moca scale score below 21 points; (2) Consistent with the clinical manifestations of cognitive dysfunction, imaging examinations, neuropsychological scales, etc.; (3) Imaging lesions, course of disease: within 18 months; (5) Age: 18-80 years old; (6) The results of non-invasive cardiac output measurement/pulmonary ventilation function measurement/cardiopulmonary exercise test were determined by stable basic disease control, stable vital signs, and able to cooperate with treatment. (7) Patients and their families voluntarily cooperate and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Vital signs are unstable; (2) Cerebral hemorrhage; (3) Combined with dissecting aneurysm, moderate to severe aortic regurgitation, significant pulmonary hypertension, active phlebitis, venous thrombosis, pregnancy, and arterial occlusive disease of the lower limbs. (4) Severe circulatory system, respiratory system, locomotor system and other diseases, such as severe atrial fibrillation, heart failure, lung infection, severe liver and kidney insufficiency and other serious disease states; (5) Combined with other diseases of the nervous system; (6) Skin ulceration and infection of both lower limbs caused by other reasons, such as fractures of both lower limbs, diabetes, etc.; (7) Unable to cooperate with the completion of examinations, such as mental disorders, severe vision and hearing abnormalities, etc.; (8) Patients with abnormal coagulation function; (9) Other reasons: refusal to participate.

Design outcomes

Primary

MeasureTime frame
Cardiac output;EEG signals;Montreal Cognitive Assessment and Mini-mental State Examiniation and Developmental Screen Test;

Countries

China

Contacts

Public ContactWei Yanxia

Nanyang Central Hospital

1536950086@qq.com+86 185 3895 3893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026